C4 Therapeutics (CCCC)
(Delayed Data from NSDQ)
$6.50 USD
+0.06 (0.93%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $6.49 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.37 | 0.00% |
Earnings Summary
For their last quarter, C4 Therapeutics (CCCC) reported earnings of -$0.41 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for CCCC's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year increase of 49.32%.
Earnings History
Price & Consensus
Zacks News for CCCC
C4 Therapeutics (CCCC) Soars 13.7%: Is Further Upside Left in the Stock?
CCCC: What are Zacks experts saying now?
Zacks Private Portfolio Services